docetaxel

美 　英

• 網(wǎng)絡(luò)多西他賽；多西紫杉醇；多烯紫杉醇

例句

Gefitinib failed to show superiority to placebo as second- or third-line treatment, but it has been shown to be non inferior to docetaxel.

吉非替尼在二線和三線治療中與安慰劑相比無優(yōu)勢，但其作用不遜于多西他賽。

Docetaxel is a chemotherapeutic drug which has recently demonstrated high efficacy in the treatment of a wide variety of tumors.

多西紫杉醇是一種化療藥物，最近還證明在一個多種腫瘤的治療療效高。

The overall response rate (ORR) tended to be higher with both weekly nab-paclitaxel regimens than docetaxel by independent radiology review.

通過獨立的放射學(xué)復(fù)查，蛋白結(jié)合型紫杉醇單周方案的總有效率（ORR）要比紫杉醇高。

Methods: Docetaxel liposomes were prepared by modified film dispersion-high pressure homogenization and lyophilization.

方法：采用改良薄膜分散法結(jié)合冷凍干燥工藝制備多西他賽脂質(zhì)體凍干粉；

Finally, they tested the approach in mice with an ovarian cancer cell line known to be resistant to taxane-based drugs such as docetaxel.

最后，他們檢測了對紫衫烷為基礎(chǔ)的藥物如紫杉萜抵抗的卵巢癌細(xì)胞系的小鼠。

ABSTRACT: Objective To optimize the preparation and formulation of docetaxel-containing liposome.

摘要：目的優(yōu)化制備多西紫杉醇脂質(zhì)體的工藝和處方。

Use abiraterone for patients with castrate -resistant metastatic prostate cancer who have failed docetaxel (Taxotere).

使用阿比特龍治療既往接受過多烯紫杉醇（泰素帝）化療的去勢難治性晚期（轉(zhuǎn)移性）前列腺癌患者。

Objective To evaluate the efficacy, toxicity and safety of docetaxel and epirubicin in the treatment of advanced breast cancer.

目的觀察多西他賽聯(lián)合表阿霉素治療晚期乳腺癌的臨床療效及毒副作用，并對安全性進(jìn)行評估。

Therefore, it could be concluded that pro-mixed docetaxel micelles has the potential of clinical applications.

綜合上述研究可見，多西紫杉醇前體混合膠束具有良好的應(yīng)用前景。

Docetaxel has demonstrated superiority compared with best supportive care.

多西他賽證明效果優(yōu)于最好的支持療法。

In the present study docetaxel was chosen as candidate of the ovarian tumor cell targeting drug delivery system.

因此本研究在制備能靶向于卵巢癌細(xì)胞的給藥系統(tǒng)時，選擇多烯紫杉醇作為模型藥物。

In the present study, we incorporated docetaxel (DTX) into an injectable thermo-sensitive mixed micelle gel (MMG).

在本研究中，我們納入一個熱敏感注射混合膠束凝膠（MMG），多西紫杉醇（DTX）。

Objective HPLC method was established for injection of docetaxel content.

目的建立了HPLC法測定注射用多西他賽的含量。

New advances in chemotherapy include paclitaxel and docetaxel.

化療新進(jìn)展包括紫杉醇和多烯紫杉醇。

Objective: To prepare docetaxel liposomes and characterize its in vitro and in vivo properties.

目的：制備多西他賽脂質(zhì)體，對其體內(nèi)外性質(zhì)進(jìn)行評價。

A phase II study evaluated gefitinib and docetaxel as second-line therapy .

一項II期臨床試驗對gefitinib和多西他賽作為二線治療方案進(jìn)行檢驗。

Such findings confirm the data from Fidias et al with respect to docetaxel, and the 4 studies had a similar design.

這種研究發(fā)現(xiàn)證實了來自Fidias等關(guān)于多西他賽的研究結(jié)果，而且4項大型的臨床研究都有相似的試驗設(shè)計。

Data suggest that docetaxel (T) may add to the efficacy of PF.

數(shù)據(jù)表明多西他賽（T）可能增加PF方案的有效性。

The other taxane, Taxotere (docetaxel) is more potent than Taxol.

另一紫杉烷，泰索帝（紫杉萜）比紫杉醇更有效。

Recent years , there are many studys about docetaxel-base regimen in patients with advanced gastric in the world.

近年來國際上報道了大量含多西紫杉醇的方案治療晚期胃癌的研究。

Mice with control siRNA plus docetaxel saw reductions of 67 and 84 percent.

而對照組siRNA加紫杉萜治療的小鼠分別減少了67%和84%。

Conversely, distant relapse and metastasis was lower with docetaxel plus FEC : 17. 7% vs 21. 8%.

相反的，遠(yuǎn)端再發(fā)以及轉(zhuǎn)移比例同樣較低，為17.7%相較于21.

AIM: To study the efficiency and toxicities of docetaxel gemcitabine combination on advanced non small cell lung cancer (NSCLC).

前言：目的：研究健擇和多西紫杉醇聯(lián)合方案治療晚期非小細(xì)胞肺癌（NSCLC）的療效。

Objective: To study the proliferation inhibition effect of docetaxel combined with cisplatin on osteosarcoma cells.

目的：研究多西紫杉醇聯(lián)合順鉑對人骨肉瘤細(xì)胞的增殖抑制作用。

Trials on Docetaxel Plus Cisplatin Semimonthly Therapy Versus that of Triweekly Therapy in Advanced Nonsmall-cell Lung Cancer

紫杉醇聯(lián)合順鉑雙周方案與三周方案治療晚期非小細(xì)胞肺癌的對比研究

Clinical study of treatment with docetaxel for injection combined with cisplatin for advanced non-small cell lung cancer

國產(chǎn)多西紫杉醇聯(lián)合順鉑治療晚期非小細(xì)胞肺癌的臨床研究

Clinical study of docetaxel combination with carboplatin as front-line therapy in advanced non-small cell lung cancer

多西他賽聯(lián)合卡鉑一線治療晚期非小細(xì)胞肺癌的臨床觀察

Application of Standardized Preventive Nursing Intervention in Chemotherapy with Docetaxel for Injection

預(yù)防性規(guī)范化護(hù)理干預(yù)在注射用多西他賽化療中的應(yīng)用

Three dimensional-conformal radiotherapy combined with weekly docetaxel chemotherapy for locally advanced non-small cell lung cancer

三維適形放療聯(lián)合周劑量多西他賽治療局部晚期非小細(xì)胞肺癌療效觀察

The evaluations of different age advanced non-small-cell lung cancer patients treated with docetaxel plus platinum combination chemotherapy

泰索帝聯(lián)合鉑類用于不同年齡晚期非小細(xì)胞肺癌的分析

Analyses of clinical results of treatment with docetaxel and megestrol acetate for treating hormone-resistance prostate carcinoma

多西他塞聯(lián)合甲地孕酮治療激素抵抗性前列腺癌療效觀察

Clinical study on chrono-chemotherapy of docetaxel administration weekly for elderly patients with advanced non-small cell lung cancer

多西他賽每周用藥時辰化療治療老年晚期非小細(xì)胞肺癌的臨床研究

Experimental study on apoptosis of ovarian cancer cells and reversal docetaxel drug resistance induced by Survivin antisense RNA

Survivin反義核酸誘導(dǎo)卵巢癌細(xì)胞凋亡及逆轉(zhuǎn)多西他賽耐藥機(jī)制的實驗研究

Clinical observation of concurrent chemoradiotherapy with docetaxel for advanced non- small cell lung cancer

放療同步多西他賽化療治療晚期非小細(xì)胞肺癌的臨床觀察

A clinical study of docetaxel combined with ifosamide in the treatment of recurrent advanced non-small cell lung cancer

多西他塞聯(lián)合異環(huán)磷酰胺治療晚期復(fù)發(fā)非小細(xì)胞肺癌的臨床觀察

Clinical Observation of the Effect of Weekly Docetaxel with Synchronous Radiotherapy on Patients with Esophageal Cancer

每周一次多西他賽同步放射治療食管癌臨床療效觀察

Docetaxel plus oxaliplatin in treatment of platinum resistance advanced epithelia ovary cancer

多西他賽聯(lián)合奧沙利鉑治療鉑類耐藥的晚期卵巢上皮癌

The antitumor and radiosensitization effects of docetaxel on human hepatocellular carcinoma in vivo

多烯紫杉醇在體內(nèi)對肝癌的抑制和放射增敏作用

Weekly administration of gemcitabine and docetaxel combinations in the treatment of advanced non-small cell lung cancer

健擇加泰索帝每周給藥治療晚期非小細(xì)胞肺癌的臨床研究

Stability study of docetaxel injections

多西紫杉醇注射液的穩(wěn)定性考察